Horizontal and vertical consolidation among hospitals, physician groups and other providers has increased market concentration in many geographic areas. Typically when markets become more concentrated, prices are likely to go up. Providers have reacted to concerns about the increased concentration by claiming they are creating scale efficiencies that will reduce costs and are engaging in better care coordination. (I am trying not to gag.) Research carried in Health Affairs looks at the association between the level of concentration among orthopedic surgeons and fees for knee replacement surgery. (HA Article) Surgeries are relatively expensive medical procedures and account for around a third of all US health spending. The surgeon fee portion is typically significantly smaller than the facility fee, but is still a substantial part of the total cost. The authors used a large commercial claims data base to determine fees paid for knee replacement in 311 counties over the period 2001 to 2010. The primary analysis involved tracking changes in concentration within a county over time and the potential relationship between concentration and fees. Using the common Herfindahl-Hirschman Index to measure market concentration, the authors found that most counties had some level of concentration throughout the study period and that concentration rose modestly during the study period. The average physician fee during the period was $2537, but in the third quartile of markets ranked by increasing concentration, the fees were about 4% higher and in the highest quartile they were about 7% higher. The results accord with basic economics and suggest that if consolidation among providers does result in cost efficiencies, those are being retained by the providers, not shared with payers, and the providers are raising prices at the same time.
Market Concentration Increases Orthopedic Surgery Fees
No Comments
✅ Subscribe via Email
About this Blog
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
Karl Marx
February 10, 2025
Karl Marx
Karl Marx was essentially an idiot whose ideas have been adopted by totalitarians to justify…
Commentary
Debunking Climate Hysteria, February 9, 2025
February 9, 2025
Debunking Climate Hysteria, February 9, 2025
The latest in our irregular efforts to spread climate truth.
Commentary
Bob Dylan, Part 1
February 9, 2025
Bob Dylan, Part 1
A recent movie on Bob Dylan is worth a watch, but his songs are what…